unilateral acute idiopathic maculopathy
Recently Published Documents


TOTAL DOCUMENTS

38
(FIVE YEARS 8)

H-INDEX

11
(FIVE YEARS 1)

Author(s):  
Ramesh Venkatesh ◽  
Nikitha Gurram Reddy ◽  
Ram Snehith Pulipaka ◽  
Padmamalini Mahendradas ◽  
Naresh Kumar Yadav ◽  
...  

Author(s):  
J.L. Sánchez-Vicente ◽  
A. Moruno-Rodríguez ◽  
J. de las Morenas-Iglesias ◽  
T. Rueda-Rueda ◽  
B. Lechón-Caballero ◽  
...  

Author(s):  
Leonardo Ferreira Jorge ◽  
Rafael de Pinho Queiroz ◽  
Fabio Gasparin ◽  
Daniel Vítor Vasconcelos-Santos

2019 ◽  
Vol 15 ◽  
pp. 100464 ◽  
Author(s):  
Rodrigo Crispim Dompieri ◽  
Roberta Pereira de Almeida Manzano ◽  
Maria Auxiliadora Monteiro Frazão ◽  
Helena Yuri Kurimori ◽  
John Chii Tyng Chao ◽  
...  

2017 ◽  
Vol 28 (2) ◽  
pp. 256-258 ◽  
Author(s):  
Georgios Mylonas ◽  
Franz Prager ◽  
Barbara Wetzel ◽  
Panagiotis Malamos ◽  
Gabor Deak ◽  
...  

Purpose: To describe a case of unilateral acute idiopathic maculopathy (UAIM) response to intravitreal therapy with aflibercept (Eylea). Methods: Retrospective case report. Results: A 36-year-old woman with sudden visual impairment and central scotoma was found to have a UAIM in her left eye. Three weeks after continuous worsening of her visual acuity and central scotoma, the patient was treated with intravitreal injections of aflibercept. The visual acuity increased and the macula lesion regressed, causing macula scarring after 2 injections. Conclusions: Intravitreal injections of aflibercept could be a therapy option in patients with UAIM without signs of spontaneous resolution of the clinical manifestations and visual improvement.


Sign in / Sign up

Export Citation Format

Share Document